CBT — Cabot
Median target
$80
calls from the last 12 months
Implied return
+3.1%
median target vs. price
Coverage
4 analysts · 4 calls
updated in the last 12 months
Consensus
1/2/10 net
Buy / Hold / Sell
Which analysts are behind CBT's consensus?
See every current rating, price target and the analysts' track records for Cabot — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 4 analysts with calls on CBT updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
CBT elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-08-28 | Insiders | Keohane Sean DPresident and CEO | Insider sale | 134.9K sh @ $85.00 | $11.5M |
| 2026-08-24 | Insiders | Keohane Sean DPresident and CEO | Insider sale | 2.8K sh @ $85.50 | $238K |
| 2026-08-07 | Insiders | Keohane Sean DPresident and CEO | Insider sale | 91.9K sh @ $86.41 | $7.9M |
| 2019-12-04 | Congress | Lois FrankelFL-FL22 | Sale | since trade +96.7%, vs market +72.2% | $1K–$15K |
| 2019-12-03 | Congress | Lois FrankelFL-FL22 | Sale | since trade +98.6%, vs market +71.9% | $1K–$15K |
| 2015-05-27 | Congress | Thomas MacArthurNJ-NJ03 | Sale | since trade +140.4%, vs market +190.1% | $1K–$15K |
More: congressional trades on CBT · insider activity · executive branch · trending